NEW research published in The
Lancet has demonstrated that
people treated with a blood clot
dissolving drug within three hours
of suffering a stroke have better
and faster recovery.
Involving more than 6,700
patients, the study showed
that those who received the
drug alteplase had a 75% better
outcome if they were treated
within the first three hours of
a stroke but the benefit rapidly
declined if treatment was delayed
by even a few hours.
Study co-author Professor
Richard Lindley from University
of Sydney said the study showed
that treatment with alteplase
significantly increased the odds of a
good stroke outcome.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Aug 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Aug 14
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.